Nectarine Health™ at Home now registered with the FDA
Brighter AB (publ) announced today that its subsidiary Pink Nectarine Health AB and the remote care system Nectarine Health™ at Home have now been registered with the U.S. Food and Drug Administration (FDA), listing the care system as a Class II medical device. Although filing with the FDA was not mandatory, Nectarine Health believes that it may open up other sales channels.
“The FDA registration of Nectarine Health™ at Home is another important step in our effort to commercialise our product. We believe that our Class II registration will support us as we explore opportunities with selected partners in the US healthcare market” says Matthias Tietze, CEO of Nectarine Health.
For more information, please contact:
Investor Relations
ir@brighter.se
Certified Adviser
Brighter's Certified Adviser is Eminova Fondkommission AB, +46 (0)8 - 684 211 00, adviser@eminova.se, www.eminova.se.
About Nectarine Health
Nectarine Health™ at Home is an AI-based well-being technology that is built for life-loving independence. It aims to empower seniors to live more fully and independently at home for longer, and to help them feel safe in the knowledge that help is always at hand, without compromising on their privacy or dignity. Nectarine Health is an international company with a team of 40 and headquarters in Gamla Stan, Stockholm, Sweden. We believe that better and more intelligent tools can help society improve and maintain the quality of care for its ageing global population.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.
For more information, please visit our website at www.brighter.se